Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.76 Bil Enterprise Value: 31.84 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Coloplast A/S to Discuss Complete Acquisition of Kerecis Call Transcript

Sep 04, 2023 / 12:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Coloplast conference call on the closing of the acquisition of Kerecis. (Operator Instructions)

I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Good afternoon, everyone, and welcome to this conference call on the completion of the acquisition of Kerecis. I'm Kristian Villumsen, the CEO of Coloplast. And today, I have the distinct pleasure to introduce to you Fertram Sigurjonsson, the CEO and Founder of Kerecis. Fertram will speak about the unique fish skin technology that Kerecis has developed and the great work done by the team in bringing the technology to the market and already helping tens of thousands of patients.

As usual, I'm also joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We'll start with a short presentation and then open up for questions like we usually do

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot